Inti H. Peredo

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.

Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.

Journal: EBioMedicine

Published: February 18, 2018

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.

Journal: Oncotarget

Published: February 25, 2017

Tumor-infiltrating lymphocytes (TILs) from patients with glioma.

Tumor-infiltrating lymphocytes (TILs) from patients with glioma.

Journal: Oncoimmunology

Published: June 09, 2016

Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.

Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.

Journal: BMJ case reports

Published: December 17, 2015

Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.

Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.

Journal: Oncoimmunology

Published: April 20, 2015

Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.

Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: prognostic significance and biological impact.

Journal: Cell death and differentiation

Published: April 08, 2015

Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery.

Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery.

Journal: Oncoimmunology

Published: January 29, 2015

Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.

Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.

Journal: Oncoimmunology

Published: October 08, 2014

Questionable debate on antiviral therapy in malignant glioblastoma

Questionable debate on antiviral therapy in malignant glioblastoma

Journal: Lakartidningen

Published: August 28, 2014

Valganciclovir in patients with glioblastoma.

Valganciclovir in patients with glioblastoma.

Journal: The New England journal of medicine

Published: November 22, 2013

Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.

Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.

Journal: International journal of cancer

Published: November 22, 2013

Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study.

Increased survival using delayed gamma knife radiosurgery for recurrent high-grade glioma: a feasibility study.

Journal: World neurosurgery

Published: July 09, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026